Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alfred

Showing results (31-40 of 434) with videos related to

Pageof 44
Sort By:
European Urology|June 29, 2013
A case of abiraterone acetate withdrawalJ Alfred Witjes
Urology|December 8, 2009
Editorial commentJ Alfred Witjes
European Urology|August 30, 2008
Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomyJ Alfred Witjes
Urologic Oncology|May 6, 2009
Management of the first recurrence of T1G3 bladder cancer: does intravesical chemotherapy deserve a chance?J Alfred Witjes
European Urology|August 8, 2015
The Final Answer to the Question of Whether We Should Use a Single Postoperative Instillation of Chemotherapy After Resection of pTa and pT1 Bladder TumorsJ Alfred Witjes
European Urology|May 29, 2007
What is the optimal BCG dose in non-muscle-invasive bladder cancer?J Alfred Witjes
European Urology|March 29, 2022
Re: Oncological Benefit of Re-resection for T1 Bladder Cancer: A Comparative Effectiveness StudyJ Alfred Witjes
European Urology|October 9, 2018
Radiofrequency-induced Thermochemotherapy for Recurrent Non-muscle-invasive Bladder Cancer: A New Treatment for an Unmet Need?J Alfred Witjes
European Urology|April 26, 2025
Follow-up for Non-muscle-invasive Bladder Cancer: Should the Guidelines Be Adapted?J Alfred Witjes
Pharmacotherapy|November 8, 2017
Comparison of Fecal Blood Loss after Use of Aspirin and DiflunisalJ Alfred Rider
Pageof 44

Showing results (31-40 of 434) with videos related to

Sort By:
Pageof 44
European Urology|June 29, 2013
A case of abiraterone acetate withdrawalJ Alfred Witjes
Urology|December 8, 2009
Editorial commentJ Alfred Witjes
European Urology|August 30, 2008
Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomyJ Alfred Witjes
Urologic Oncology|May 6, 2009
Management of the first recurrence of T1G3 bladder cancer: does intravesical chemotherapy deserve a chance?J Alfred Witjes
European Urology|August 8, 2015
The Final Answer to the Question of Whether We Should Use a Single Postoperative Instillation of Chemotherapy After Resection of pTa and pT1 Bladder TumorsJ Alfred Witjes
European Urology|May 29, 2007
What is the optimal BCG dose in non-muscle-invasive bladder cancer?J Alfred Witjes
European Urology|March 29, 2022
Re: Oncological Benefit of Re-resection for T1 Bladder Cancer: A Comparative Effectiveness StudyJ Alfred Witjes
European Urology|October 9, 2018
Radiofrequency-induced Thermochemotherapy for Recurrent Non-muscle-invasive Bladder Cancer: A New Treatment for an Unmet Need?J Alfred Witjes
European Urology|April 26, 2025
Follow-up for Non-muscle-invasive Bladder Cancer: Should the Guidelines Be Adapted?J Alfred Witjes
Pharmacotherapy|November 8, 2017
Comparison of Fecal Blood Loss after Use of Aspirin and DiflunisalJ Alfred Rider
Pageof 44